Previous close | 113.93 |
Open | 113.95 |
Bid | 113.00 x 800 |
Ask | 120.00 x 2200 |
Day's range | 114.01 - 117.43 |
52-week range | 66.89 - 134.76 |
Volume | |
Avg. volume | 2,514,206 |
Market cap | 45.273B |
Beta (5Y monthly) | 1.11 |
PE ratio (TTM) | 22.52 |
EPS (TTM) | 5.20 |
Earnings date | 26 Apr 2023 - 01 May 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 129.95 |
BURNABY, British Columbia, March 21, 2023--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced that its Dexcom G6 CGM System will be available to people of all ages with type 1 and type 2 diabetes in Manitoba who meet eligibility criteria.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Superstar recording artist Nick Jonas shares his experience with diabetes and why he's using his platform to improve access to diabetes care. Nick joins Yahoo Finance Senior Reporter Allie Garfinkle from SXSW in Austin, TX to discuss how health technology like continuous glucose monitoring (CGM) is easing the burden of managing diabetes. Watch as Nick opens up about his partnership with DexCom (DXCM), fatherhood, and his struggle with diabetes.